V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10208752 | 10054979 | 1.74 | 62.2 | Palliative (P) | 2019-05-26 | 2019-05-29 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101569584 |
| 10208849 | 10054981 | 1.75 | 73.9 | null | null | 2018-09-24 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100114234 |
| 10209385 | 10054982 | 1.57 | null | null | null | 2022-03-30 | Avelumab | 02 | null | AVELUMAB | 100890055 |
| 10209468 | 10054983 | null | 84.9 | null | 2017-04-17 | 2017-05-24 | DARATUMUMAB | 02 | null | DARATUMUMAB | 100484995 |
| 10209661 | 10054984 | null | 90 | null | 2020-02-14 | 2020-02-14 | DARATUMUMAB | 02 | null | DARATUMUMAB | 101542876 |
| 10209795 | 10054985 | 1.82 | 79.6 | null | 2019-02-03 | 2019-05-13 | Avelumab | 02 | null | VENETOCLAX | 100460136 |
| 10209860 | 10054986 | null | 100 | null | 2017-01-06 | 2017-07-24 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101658124 |
| 10209910 | 10054987 | 1.7 | 88 | null | 2021-07-31 | 2021-12-25 | Avelumab | 02 | null | DARATUMUMAB | 100011953 |
| 10209994 | 10054988 | 1.53 | null | null | 2019-05-07 | 2019-05-25 | Avelumab | 02 | null | TRASTUZUMAB | 100980107 |
| 10210080 | 10054989 | 1.66 | 93.4 | null | 2019-12-16 | 2019-12-26 | Avelumab | 02 | null | FLUOROURACIL + IRINOTECAN | 100626030 |
| 10210142 | 10054990 | 1.73 | 77.6 | Palliative (P) | 2018-04-09 | 2018-12-01 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100073099 |
| 10210326 | 10054991 | 1.54 | 104 | Palliative (P) | 2012-03-09 | 2021-10-18 | CEMIPLIMAB | N | N | CEMIPLIMAB | 100629613 |
| 10210462 | 10054992 | 1.68 | 92 | Palliative (P) | 2019-10-30 | 2019-11-27 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100071555 |
| 10210868 | 10054993 | 1.81 | 87.2 | 03 | 2019-11-21 | 2019-11-23 | Avelumab | 02 | N | CAPECITABINE + OXALIPLATIN | 100490163 |
| 10210917 | 10054994 | 1.85 | 88.78 | Neo-adjuvant (N) | 2019-04-21 | 2019-05-07 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101240062 |
| 10211934 | 10054997 | 1.63 | 0 | null | 2019-08-17 | 2019-08-18 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100425491 |
| 10212151 | 10054998 | 1.6 | 66.3 | null | null | 2020-10-21 | RUXOLITINIB | 02 | null | TRASTUZUMAB | 100254260 |
| 10212541 | 10055000 | 1.68 | 65.8 | Palliative (P) | null | 2022-01-01 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100937680 |
| 10212733 | 10055001 | 1.75 | 82.4 | Palliative (P) | 2020-06-01 | 2020-06-22 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 101589676 |
| 10212791 | 10055002 | 1.56 | 81.2 | null | 2020-01-31 | 2020-02-13 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100478455 |
| 10213680 | 10055004 | 1.84 | 45.8 | null | 2017-09-08 | 2017-09-21 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100538817 |
| 10213771 | 10055005 | 1.62 | 82 | null | null | 2018-06-17 | Irinotecan + Modified De Gramont | null | null | FLUOROURACIL + IRINOTECAN | 100828085 |
| 10213958 | 10055006 | null | 79.5 | Palliative (P) | null | 2017-08-08 | Avelumab | 02 | null | FLUOROURACIL + IRINOTECAN | 100556054 |
| 10214003 | 10055007 | 1.63 | 71.7 | Palliative (P) | null | 2019-01-08 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101153356 |
| 10214334 | 10055009 | 1.62 | 105 | 03 | 2016-12-28 | 2017-01-05 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100231750 |
| 10214479 | 10055010 | 1.66 | 55.5 | Palliative (P) | 2020-08-02 | 2020-08-26 | Avelumab | 02 | N | VENETOCLAX | 100138752 |
| 10214532 | 10055012 | 1.74 | null | null | null | 2018-02-19 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100052773 |
| 10215206 | 10055014 | 1.63 | 64.1 | null | null | 2019-05-25 | Avelumab | 02 | null | BENDAMUSTINE + RITUXIMAB | 100484171 |
| 10215223 | 10055015 | 1.71 | 86 | null | null | 2017-08-01 | Avelumab | 02 | null | FLUOROURACIL + IRINOTECAN | 100587209 |
| 10215401 | 10055016 | 1.61 | 50 | null | 2020-01-28 | 2021-03-18 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100601546 |
| 10215460 | 10055017 | 1.79 | 92 | null | 2019-07-20 | 2019-07-28 | RUXOLITINIB | 02 | null | VENETOCLAX | 100856114 |
| 10216417 | 10055020 | null | 0 | Palliative (P) | 2019-04-05 | 2019-04-22 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101149229 |
| 10216522 | 10055021 | 1.7 | 80 | Palliative (P) | null | 2018-01-15 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101173311 |
| 10216580 | 10055022 | 1.77 | 77.8 | null | 2018-10-24 | 2018-10-26 | Venetoclax | 02 | null | VENETOCLAX | 101810432 |
| 10216825 | 10055023 | 1.66 | 80 | null | 2020-09-13 | 2020-11-03 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100728143 |
| 10216933 | 10055024 | 1.55 | 79.6 | Palliative (P) | 2018-02-16 | 2020-12-10 | Venetoclax | 02 | N | VENETOCLAX | 100517198 |
| 10217275 | 10055025 | 1.66 | 78.3 | null | null | 2017-08-17 | Avelumab | 02 | null | CAPECITABINE + OXALIPLATIN | 100525459 |
| 10217601 | 10055027 | 1.83 | 64.7 | null | 2021-07-09 | 2021-07-23 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 100019602 |
| 10217766 | 10055028 | 1.63 | 61 | null | 2021-11-07 | 2021-12-25 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 101733308 |
| 10217817 | 10055030 | 1.7 | 84.9 | Disease modification (D) | 2019-08-23 | 2019-08-26 | Avelumab | 02 | N | CAPECITABINE + OXALIPLATIN | 101679940 |
| 10218005 | 10055031 | 0 | 59.8 | Adjuvant (A) | 2014-06-27 | 2017-06-03 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 101762117 |
| 10218168 | 10055032 | 1.57 | 80.2 | Palliative (P) | 2022-05-22 | 2022-05-28 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101591776 |
| 10218407 | 10055033 | 1.54 | 79 | null | 2021-04-11 | 2021-12-24 | FLUOROURACIL + OXALIPLATIN | 2 | null | FLUOROURACIL + OXALIPLATIN | 101524091 |
| 10218522 | 10055034 | 1.7 | 44.6 | Neo-adjuvant (N) | 2021-08-08 | 2021-10-04 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100486308 |
| 10218775 | 10055035 | 1.85 | 70.5 | null | 2019-08-13 | 2019-08-16 | DARATUMUMAB | 02 | null | DARATUMUMAB | 101292198 |
| 10219850 | 10055037 | 1.7 | 77 | Palliative (P) | 2019-12-24 | 2019-12-25 | Venetoclax | 02 | null | VENETOCLAX | 100059073 |
| 10220369 | 10055039 | 1.72 | 75.4 | null | 2019-12-17 | 2019-12-21 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 100806009 |
| 10220481 | 10055040 | 0 | 74.9 | null | 2019-12-19 | 2019-12-26 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100227748 |
| 10220942 | 10055041 | 1.71 | 49.9 | null | 2018-03-09 | 2018-03-12 | DARATUMUMAB | 02 | null | DARATUMUMAB | 100532469 |
| 10221115 | 10055042 | 1.91 | 88 | null | 2018-01-12 | 2018-01-13 | FLUOROURACIL + OXALIPLATIN | 02 | null | FLUOROURACIL + OXALIPLATIN | 101491537 |